Prostaglandin E2 induces immediate migraine-like attack in migraine patients without aura (Q57023979)

https://api.crossref.org/works/10.1177%2F0333102412451360

Prostaglandin E2 and pain--an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

Spinal administration of prostaglandin E(2) or prostaglandin F(2alpha) primarily produces mechanical hyperalgesia that is mediated by nociceptive specific spinal dorsal horn neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

Nociceptive effects induced by intrathecal administration of prostaglandin D2, E2, or F2 alpha to conscious mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

Functional and molecular characterization of prostaglandin E2 dilatory receptors in the rat craniovascular system in relevance to migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

BGC20-1531, a novel, potent and selective prostanoid EP receptor antagonist: a putative new treatment for migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

Characterization of the prostanoid receptor types involved in mediating calcitonin gene-related peptide release from cultured rat trigeminal neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

Regulation of calcitonin gene-related peptide release from rat trigeminal nucleus caudalis slices in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

Prostacyclin (epoprostenol) induces headache in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

Prostaglandin E2(PGE2) induces headache in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

Prostaglandin I2 (epoprostenol) triggers migraine-like attacks in migraineurs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

The International classification of headache disorders, 2nd edn (ICDH-II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

PACAP38 induces migraine-like attacks in patients with migraine without aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

Analysis of serial measurements in medical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

CGRP may play a causative role in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

Carbachol induces headache, but not migraine-like attacks, in patients with migraine without aura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

The cholinomimetic agent carbachol induces headache in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

Small arteries can be accurately studied in vivo, using high frequency ultrasound.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

Prostaglandin E2 receptor EP4 contributes to inflammatory pain hypersensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

Distribution, regulation and colocalization of the genes encoding the EP2- and EP4-PGE2 receptors in the rat brain and neuronal responses to systemic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

Prostanoids and pain: unraveling mechanisms and revealing therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

Acute and persistent nociceptive paw sensitisation in mice: the involvement of distinct signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

GlyR alpha3: an essential target for spinal PGE2-mediated inflammatory pain sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

Pain modulatory actions of cytokines and prostaglandin E2 in the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

Effects of selective COX-1 and -2 inhibition on formalin-evoked nociceptive behaviour and prostaglandin E(2) release in the spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

Inflammatory responses to intradermal injection of platelet activating factor, histamine and prostaglandin E2 in healthy volunteers: a double blind investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

Localization of COX-1 and COX-2 in the intracranial dura mater of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

Sensitization of central trigeminovascular neurons: blockade by intravenous naproxen infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

Sensitization of meningeal nociceptors: inhibition by naproxen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

Response properties of trigeminal brain stem neurons with input from dura mater encephali in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

Sensitization and activation of intracranial meningeal nociceptors by mast cell mediators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

Modulation of dural nociceptor mechanosensitivity by the nitric oxide-cyclic GMP signaling cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: implications for the pathophysiology of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

IL-1β stimulates COX-2 dependent PGE₂ synthesis and CGRP release in rat trigeminal ganglia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

Characterization of EP-receptor subtypes involved in allodynia and hyperalgesia induced by intrathecal administration of prostaglandin E2 to mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

CJ-023,423, a novel, potent and selective prostaglandin EP4 receptor antagonist with antihyperalgesic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

The pharmacological effect of BGC20-1531, a novel prostanoid EP4 receptor antagonist, in the prostaglandin E2 human model of headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

Blockade by ONO-NT-012, a unique prostanoid analogue, of prostaglandin E2-induced allodynia in conscious mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360

Trigeminal nociceptors express prostaglandin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451360